Price Alert

Apexigen Inc. (APGN)

NASDAQ: APGN · Real-Time Price · USD

0.39

0.04 (9.86%)

At close: Aug 22, 2023, 9:59 PM

Apexigen Statistics

Share Statistics

Apexigen has 24.86M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	24.86M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	22.08M
Failed to Deliver (FTD) Shares	189
FTD / Avg. Volume	0.07%

Short Selling Information

The latest short interest is 107.25K, so 0.43% of the outstanding shares have been sold short.

Short Interest	107.25K
Short % of Shares Out	0.43%
Short % of Float	0.45%
Short Ratio (days to cover)	3.8

Valuation Ratios

The PE ratio is -0.43 and the forward PE ratio is null. Apexigen's PEG ratio is -0.01.

PE Ratio	-0.43
Forward PE	n/a
PS Ratio	0
Forward PS	n/a
PB Ratio	2.12
P/FCF Ratio	-0.44
PEG Ratio	-0.01

Financial Ratio History

Enterprise Valuation

Apexigen has an Enterprise Value (EV) of -1.2M.

EV / Sales	0
EV / EBITDA	0.04
EV / EBIT	0.04
EV / FCF	0.04

Financial Position

The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.02.

Current Ratio	1.29
Quick Ratio	1.29
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	52.98

Financial Efficiency

Return on Equity is -493.21% and Return on Invested Capital is -494.48%.

Return on Equity	-493.21%
Return on Assets	-137.62%
Return on Invested Capital	-494.48%
Revenue Per Employee	n/a
Profits Per Employee	$-2.86M
Employee Count	11
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	-617K
Effective Tax Rate	1.92%

Stock Price Statistics

The stock price has increased by 1.3% in the last 52 weeks. The beta is 3.62, so Apexigen's price volatility has been higher than the market average.

Beta	3.62
52-Week Price Change	1.3%
50-Day Moving Average	0.42
200-Day Moving Average	0.83
Relative Strength Index (RSI)	44.28
Average Volume (20 Days)	262,332

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-32.69M
Net Income	-31.45M
EBITDA	-32.58M
EBIT	n/a
Earnings Per Share (EPS)	-1.59

Full Income Statement

Balance Sheet

The company has 14.8M in cash and 106K in debt, giving a net cash position of 14.7M.

Cash & Cash Equivalents	14.8M
Total Debt	106K
Net Cash	14.7M
Retained Earnings	-176.79M
Total Assets	13.08M
Working Capital	-2.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -30.69M and capital expenditures -57K, giving a free cash flow of -30.75M.

Operating Cash Flow	-30.69M
Capital Expenditures	-57K
Free Cash Flow	-30.75M
FCF Per Share	-1.55

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	-233.07%
FCF Yield	-227.86%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for APGN.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-27.16
Piotroski F-Score	3